HC Wainwright & Co. Reiterates Neutral on Adicet Bioto Neutral

Benzinga12/20 00:39

Adicet Bio Announces First Patient Dosed in the Phase 1 Clinical Trial of ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma

Businesswire12/19 20:00

Adicet Bio Appoints Julie Maltzman, M.D. as Chief Medical Officer

Businesswire12/18 20:00

Adicet Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Businesswire11/30 05:44

Adicet Bio To Present At Jefferies London Healthcare Conference; Webcast At 7:30 AM ET

RTTNews11/19 19:34

Adicet Opens Enrollment For ADI-270 Phase 1 Clinical Trial In Metastatic/Advanced Clear Cell Renal Cell Carcinoma; First Gamma Delta CAR T Cell Therapy With The Potential To Address Solid Tumors Entering Clinical Trials; Preliminary Phase 1 Clinical...

Benzinga11/19 05:01